These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17458918)

  • 1. MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.
    van der Graaf M; Julià-Sapé M; Howe FA; Ziegler A; Majós C; Moreno-Torres A; Rijpkema M; Acosta D; Opstad KS; van der Meulen YM; Arús C; Heerschap A
    NMR Biomed; 2008 Feb; 21(2):148-58. PubMed ID: 17458918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra.
    Tate AR; Underwood J; Acosta DM; Julià-Sapé M; Majós C; Moreno-Torres A; Howe FA; van der Graaf M; Lefournier V; Murphy MM; Loosemore A; Ladroue C; Wesseling P; Luc Bosson J; Cabañas ME; Simonetti AW; Gajewicz W; Calvar J; Capdevila A; Wilkins PR; Bell BA; Rémy C; Heerschap A; Watson D; Griffiths JR; Arús C
    NMR Biomed; 2006 Jun; 19(4):411-34. PubMed ID: 16763971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Definition criteria for a magnetic resonance quality assurance program: multicenter study].
    Mascaro L; Strocchi S; Colombo P; Del Corona M; Baldassarri AM
    Radiol Med; 1999 May; 97(5):389-97. PubMed ID: 10432972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of brain tumours using short echo time 1H MR spectra.
    Devos A; Lukas L; Suykens JA; Vanhamme L; Tate AR; Howe FA; Majós C; Moreno-Torres A; van der Graaf M; Arús C; Van Huffel S
    J Magn Reson; 2004 Sep; 170(1):164-75. PubMed ID: 15324770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification.
    Opstad KS; Ladroue C; Bell BA; Griffiths JR; Howe FA
    NMR Biomed; 2007 Dec; 20(8):763-70. PubMed ID: 17326043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts.
    Kreis R
    NMR Biomed; 2004 Oct; 17(6):361-81. PubMed ID: 15468083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prototype decision support system for MR spectroscopy-assisted diagnosis of brain tumours.
    Underwood J; Tate AR; Luckin R; Majós C; Capdevila A; Howe F; Griffiths J; Arús C
    Stud Health Technol Inform; 2001; 84(Pt 1):561-5. PubMed ID: 11604803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
    Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
    NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-centre, web-accessible and quality control-checked database of in vivo MR spectra of brain tumour patients.
    Julià-Sapé M; Acosta D; Mier M; Arùs C; Watson D;
    MAGMA; 2006 Feb; 19(1):22-33. PubMed ID: 16477436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative MR-Spectroscopy: implementation and quality assurance on a clinical MR-scanner].
    Reinert M; Schneider P; Hofmann E; Semmler W
    Z Med Phys; 2010; 20(3):176-87. PubMed ID: 20663651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated quality control protocol for MR spectra of brain tumors.
    Wright AJ; Arús C; Wijnen JP; Moreno-Torres A; Griffiths JR; Celda B; Howe FA
    Magn Reson Med; 2008 Jun; 59(6):1274-81. PubMed ID: 18506793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combining two echo times in automatic brain tumor classification by MRS.
    García-Gómez JM; Tortajada S; Vidal C; Julià-Sapé M; Luts J; Moreno-Torres A; Van Huffel S; Arús C; Robles M
    NMR Biomed; 2008 Nov; 21(10):1112-25. PubMed ID: 18759382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region and volume dependencies in spectral line width assessed by 1H 2D MR chemical shift imaging in the monkey brain at 7 T.
    Juchem C; Merkle H; Schick F; Logothetis NK; Pfeuffer J
    Magn Reson Imaging; 2004 Dec; 22(10):1373-83. PubMed ID: 15707787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
    Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
    Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
    Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
    BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.